Blue Star Ltd approves Q2 FY27 results, reporting consolidated net profit of ₹123.91 crore, up 25.4% year on year
- Consolidated revenue was ₹2,930.95 crore, up 21.0% year on year.
- Operating margin was 6.91%, versus 7.57% a year earlier and 5.18% in the prior quarter.
- Q2 included ₹23.02 crore of exceptional income from the sale of the Medtech business; the limited-review conclusion was unmodified.
- The board approved unaudited standalone and consolidated results for Q2 and the half year ended September 30, 2026.
